{
 "@context": "https://clearank.com/llms.txt",
 "@type": "clearank:AssetAnalysis",
 "url": "https://clearank.com/stock/tilray-brands-tlry/",
 "dataUrl": "https://clearank.com/stock/tilray-brands-tlry/data.json",
 "title": "Tilray Brands (TLRY) Stock Forecast & Price Target (2026)",
 "description": "Is Tilray Brands (TLRY) a Buy or Sell today? Get the AI price forecast, cannabis and drinks segment outlook plus key risk levels. Updated daily.",
 "headline": "Tilray Brands Inc. (TLRY)",
 "published": "2026-08-20T09:27:35+00:00",
 "modified": "2026-09-11T19:22:43.169+00:00",
 "generated": "2026-09-11T21:15:58.694Z",
 "language": "en-US",
 "publisher": {
  "name": "CleaRank",
  "url": "https://clearank.com/"
 },
 "disclaimer": "Educational and informational only; not financial advice. AI-generated analysis reviewed by the CleaRank editorial team; prices delayed up to 15 minutes.",
 "asset": {
  "ticker": "TLRY",
  "name": "Tilray Brands Inc.",
  "type": "Common Stock",
  "exchange": "NASDAQ",
  "currency": "USD",
  "sector": "Healthcare",
  "industry": "Drug Manufacturers - Specialty & Generic",
  "country": "Canada",
  "website": "https://www.tilray.com"
 },
 "quote": {
  "price": 4.01,
  "previousClose": 4.14,
  "change": -0.12,
  "changePercent": -3.02,
  "open": 4.13,
  "high": 4.145,
  "low": 4.005,
  "volume": 231569,
  "averageVolume": 3170227,
  "marketCap": 569584979,
  "fiftyTwoWeekHigh": 23.2,
  "fiftyTwoWeekLow": 3.67,
  "marketOpen": false,
  "asOf": "2026-09-11T19:22:42.000Z"
 },
 "statistics": {
  "pe": -3.6834862385321094,
  "eps": -1.08,
  "dividendYield": 0,
  "beta": 1.921,
  "priceToSales": 0.6221885,
  "priceToBook": 1.3717694,
  "revenueTtm": 915454016,
  "grossMargin": 0.32132233399831034,
  "returnOnEquity": -0.06819
 },
 "technicals": {
  "rsi": 16.87,
  "macd": -0.09,
  "sma50": 4.43,
  "sma200": 6.53,
  "rsiSignal": "Oversold",
  "trend": "Bearish",
  "pricePosition": "Bearish",
  "macdSignal": "Bearish",
  "rating": "Bearish"
 },
 "analysis": {
  "rating": "Sell",
  "score": 21,
  "consensus": "Sell",
  "fairValue": 4.01,
  "analystTarget": 5.75,
  "analystCount": 1,
  "wallStreetConsensus": "Buy",
  "generatedAt": "2026-09-11T19:22:42.000Z",
  "priceAtAnalysis": 4.015,
  "volatility": {
   "daily": 3.22,
   "risk": "volatile"
  }
 },
 "tradePlan": {
  "bias": "Bearish",
  "conservativeEntry": 4.1,
  "aggressiveEntry": 4.01,
  "stopLoss": 4.33,
  "stopLossPercent": 5.77,
  "targets": [
   3.89,
   3.69,
   3.48
  ]
 },
 "projections": {
  "basis": "Monte Carlo simulation on historical return distribution, re-run daily; not price targets",
  "years": [
   {
    "year": 2027,
    "downside10th": 1.79,
    "base": 3.4,
    "upside90th": 6.46
   },
   {
    "year": 2028,
    "downside10th": 1.16,
    "base": 2.88,
    "upside90th": 7.13
   },
   {
    "year": 2029,
    "downside10th": 0.8,
    "base": 2.44,
    "upside90th": 7.41
   },
   {
    "year": 2030,
    "downside10th": 0.57,
    "base": 2.07,
    "upside90th": 7.45
   },
   {
    "year": 2031,
    "downside10th": 0.42,
    "base": 1.75,
    "upside90th": 7.35
   },
   {
    "year": 2032,
    "downside10th": 0.31,
    "base": 1.49,
    "upside90th": 7.14
   },
   {
    "year": 2033,
    "downside10th": 0.23,
    "base": 1.26,
    "upside90th": 6.86
   },
   {
    "year": 2034,
    "downside10th": 0.17,
    "base": 1.07,
    "upside90th": 6.53
   },
   {
    "year": 2035,
    "downside10th": 0.13,
    "base": 0.9,
    "upside90th": 6.18
   },
   {
    "year": 2036,
    "downside10th": 0.1,
    "base": 0.77,
    "upside90th": 5.81
   }
  ]
 },
 "faqCount": 7,
 "sources": [
  "TwelveData",
  "Wall Street consensus"
 ],
 "sections": [
  {
   "id": "price",
   "title": "TLRY Price Analysis"
  },
  {
   "id": "market-metrics",
   "title": "Market Metrics",
   "facts": {
    "Open": "$4.13",
    "Day Range": "$4.01 to $4.15",
    "Prev Close": "$4.14",
    "Volume": "231.6K",
    "52-Week Range": "$3.67 to $23.20",
    "Market Cap": "$569.58M"
   }
  },
  {
   "id": "peer-benchmarking",
   "title": "Peer Benchmarking",
   "text": [
    "Sector Position Analysis On price-to-sales, the yardstick used here in place of P/E, TLRY trades at 0.6222x, far below the sector average of 4.20x."
   ]
  },
  {
   "id": "analysis",
   "title": "TLRY Analysis",
   "text": [
    "Tilray Brands Inc. (TLRY) is exhibiting strong bearish momentum, trading below its 50-day SMA of $4.43 and 200-day SMA of $6.53. The Relative Strength Index (RSI) is significantly oversold at 16.87, suggesting a potential for a short-term reversal, but the MACD at -0.09 indicates a prevailing downward trend. Volume has been significantly below average recently, with the latest volume at 231,569 compared to an average of 3,170,227, indicating a lack of conviction behind current price action. Key resistance levels are now at the 50-day SMA and the 20-day EMA at $4.43 and $4.43 respectively, while the current price of $4.015 acts as immediate support.",
    "The company's recent earnings report showed a significant miss on EPS estimates, continuing a trend of underperformance that could pressure the stock further.",
    "Insiders have been net sellers of Tilray Brands Inc. stock, with total sales exceeding purchases, indicating a potential lack of confidence in the company's near-term prospects.",
    "The stock's RSI is at 16.87, indicating significantly oversold conditions that could lead to a short-term technical bounce or reversal.",
    "Despite current challenges, the sole Wall Street analyst covering the stock maintains a 'Buy' rating with a median price target of $5.75, suggesting potential upside.",
    "The outlook for Tilray Brands Inc. (TLRY) is cautious, with the stock currently trading at $4.015 and facing significant headwinds. The company's negative revenue growth and recent earnings misses suggest that operational improvements are still needed. Wall Street analysts maintain a 'Buy' rating with a median price target of $5.75, implying a potential upside of 43.2% if the company can execute its turnaround strategy effectively. However, the current technical setup, with the stock below key moving averages and an oversold RSI, suggests that the path to recovery may be challenging in the near term."
   ],
   "lists": {
    "ProTips": [
     "Given the oversold RSI and negative revenue growth, consider waiting for a confirmed technical bounce or positive earnings surprise before initiating a position in Tilray Brands Inc.",
     "The significant volume below average suggests a lack of strong conviction from traders; monitor for increased volume on any upward price movements as a sign of potential trend change.",
     "With insider selling and negative revenue growth, position sizing should be conservative, and a tight stop-loss below the current price is advisable due to the stock's technical weakness."
    ]
   },
   "catalysts": [
    {
     "type": "Bearish",
     "title": "Continued Earnings Misses",
     "text": "The company's recent earnings report showed a significant miss on EPS estimates, continuing a trend of underperformance that could pressure the stock further.",
     "source": "Company Earnings Report"
    },
    {
     "type": "Bearish",
     "title": "Insider Net Selling Activity",
     "text": "Insiders have been net sellers of Tilray Brands Inc. stock, with total sales exceeding purchases, indicating a potential lack of confidence in the company's near-term prospects.",
     "source": "Insider Transaction Filings"
    },
    {
     "type": "Bullish",
     "title": "Oversold Technical Conditions",
     "text": "The stock's RSI is at 16.87, indicating significantly oversold conditions that could lead to a short-term technical bounce or reversal.",
     "source": "Technical Analysis"
    },
    {
     "type": "Bullish",
     "title": "Positive Analyst Sentiment",
     "text": "Despite current challenges, the sole Wall Street analyst covering the stock maintains a 'Buy' rating with a median price target of $5.75, suggesting potential upside.",
     "source": "Wall Street Analysts"
    }
   ]
  },
  {
   "id": "key-statistics",
   "title": "Key Statistics",
   "text": [
    "Tilray Brands Inc. (TLRY) faces valuation challenges with a negative EPS of -1.08, making its P/E ratio mathematically negative and thus not comparable to sector averages. The company's revenue growth has declined by 7.8% year-over-year, contrasting sharply with the Healthcare sector's average revenue growth of 10.0%. The negative EPS and revenue contraction suggest underlying operational difficulties that are not currently supported by its valuation multiples. The current price of $4.015 is significantly below the median analyst target price of $5.75, indicating a substantial upside potential if the company can improve its fundamental performance.",
    "Tilray Brands Inc. (TLRY) recently reported an EPS of $0.05 for the quarter ending July 28, 2026, missing analyst estimates of $0.21 by a significant 76.19%, leading to a -0.99% price change. This follows a previous quarter where the company also missed estimates, reporting an EPS of -0.14 against an expected -0.16, though this resulted in a 12.5% price increase. The pattern of earnings misses suggests ongoing challenges in meeting analyst expectations and achieving profitability.",
    "Tilray Brands Inc. (TLRY) faces substantial risks including its negative revenue growth of -7.8% and a history of missing earnings estimates, as evidenced by the recent -76.19% EPS surprise. The stock is trading significantly below its key moving averages, with an oversold RSI, indicating strong technical weakness. Also, insider transactions show a net seller position, with $232.9K in sales versus $192.8K in purchases, signaling a lack of confidence from management."
   ],
   "tables": [
    {
     "caption": "",
     "columns": [],
     "rows": [
      {
       "label": "Market Cap",
       "cells": [
        "569.58M"
       ]
      },
      {
       "label": "P/E Ratio",
       "cells": [
        "N/A (Negative EPS)"
       ]
      },
      {
       "label": "EPS (TTM)",
       "cells": [
        "-1.08"
       ]
      },
      {
       "label": "Dividend Yield",
       "cells": [
        "0.00%"
       ]
      },
      {
       "label": "52 Week High",
       "cells": [
        "23.20"
       ]
      },
      {
       "label": "52 Week Low",
       "cells": [
        "3.67"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "technical-indicators",
   "title": "Technical Indicators",
   "text": [
    "Technical Rating Bearish RSI Oversold SMA Cross Bearish Price vs SMA Bearish MACD Bearish Moving averages show a lagging Death Cross (50-day: $4.432, 200-day: $6.525), price is trading below the 50-day SMA, RSI at 16.9 suggests oversold conditions; potential bounce setup."
   ],
   "facts": {
    "RSI": "Oversold",
    "SMA Cross": "Bearish",
    "Price vs SMA": "Bearish",
    "MACD": "Bearish"
   },
   "tables": [
    {
     "caption": "",
     "columns": [],
     "rows": [
      {
       "label": "RSI (14)",
       "cells": [
        "16.87"
       ]
      },
      {
       "label": "MACD",
       "cells": [
        "-0.09"
       ]
      },
      {
       "label": "SMA 50",
       "cells": [
        "4.43"
       ]
      },
      {
       "label": "SMA 200",
       "cells": [
        "6.53"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "correlations",
   "title": "Market Correlations",
   "text": [
    "How this stock moves relative to other assets",
    "Based on 1 year of daily price data. Correlations may vary over different time periods."
   ],
   "facts": {
    "Correlation with S&P 500 (SPY)": "+0.29",
    "Correlation with Nasdaq 100 (QQQ)": "+0.27",
    "Correlation with Bitcoin (BTC)": "+0.09",
    "Correlation with Gold (XAU)": "+0.04"
   }
  },
  {
   "id": "trade-plans",
   "title": "TLRY Trade Plans",
   "text": [
    "Specific entry, exit, and risk management levels",
    "Lower risk, wait for rally",
    "Higher risk, chasing the move",
    "Volatility-Adjusted Stop Loss Calculated based on RSI (16.9) and current market volatility",
    "Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3"
   ],
   "facts": {
    "TARGET 1": "$3.891",
    "TARGET 2": "$3.686",
    "TARGET 3": "$3.481",
    "STOP LOSS": "$4.332"
   }
  },
  {
   "id": "risk",
   "title": "Risk & Volatility",
   "facts": {
    "Daily Volatility": "3.22%"
   },
   "lists": {
    "Risk considerations": [
     "Monitor position sizing based on current volatility levels",
     "Consider stop-loss placement beyond recent price range",
     "Diversification helps mitigate single-stock risk exposure"
    ]
   }
  },
  {
   "id": "growth",
   "title": "Growth of $10,000",
   "text": [
    "A $10,000 investment in TLRY in July 2018 would be worth about $185 today, compared with about $27,065 for the same investment in the S&P 500 benchmark."
   ]
  },
  {
   "id": "monte-carlo",
   "title": "Monte Carlo Projection (10yr)",
   "text": [
    "CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in TLRY today could grow to about $1,907 by 2036 in the base case, with a bull case near $14,470 and a bear case around $251. Projections are statistical simulations, not guarantees."
   ]
  },
  {
   "id": "price-prediction",
   "title": "TLRY Stock Price Prediction: 2030",
   "text": [
    "CleaRank's simulation projects a price near $2.07 for TLRY by 2030 in the base case, from $4.02 today (0.5x over 4 years). The downside path ends near $0.5745. These are outcomes of a Monte Carlo simulation run on TLRY's historical return distribution, not price targets, and they assume no dividends are reinvested.",
    "Method: 10,000 simulated price paths using TLRY's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice."
   ],
   "tables": [
    {
     "caption": "TLRY simulated price paths by year",
     "columns": [
      "Year",
      "Downside (10th pct)",
      "Base case",
      "Upside (90th pct)"
     ],
     "rows": [
      {
       "label": "2027",
       "cells": [
        "$1.79",
        "$3.40",
        "$6.46"
       ]
      },
      {
       "label": "2028",
       "cells": [
        "$1.16",
        "$2.88",
        "$7.13"
       ]
      },
      {
       "label": "2029",
       "cells": [
        "$0.805",
        "$2.44",
        "$7.41"
       ]
      },
      {
       "label": "2030",
       "cells": [
        "$0.5745",
        "$2.07",
        "$7.45"
       ]
      },
      {
       "label": "2031",
       "cells": [
        "$0.4184",
        "$1.75",
        "$7.35"
       ]
      },
      {
       "label": "2032",
       "cells": [
        "$0.3092",
        "$1.49",
        "$7.14"
       ]
      },
      {
       "label": "2033",
       "cells": [
        "$0.231",
        "$1.26",
        "$6.86"
       ]
      },
      {
       "label": "2034",
       "cells": [
        "$0.1741",
        "$1.07",
        "$6.53"
       ]
      },
      {
       "label": "2035",
       "cells": [
        "$0.1322",
        "$0.9038",
        "$6.18"
       ]
      },
      {
       "label": "2036",
       "cells": [
        "$0.1009",
        "$0.7658",
        "$5.81"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "people-also-watch",
   "title": "People Also Watch",
   "links": [
    {
     "text": "HIMS Hims & Hers Health, Inc. NYSE $27.52 +0.2733%",
     "url": "https://clearank.com/stock/hims-hers-health-hims/"
    },
    {
     "text": "UNH UnitedHealth Group Inc. NYSE $388.28 -1.22%",
     "url": "https://clearank.com/stock/unitedhealth-group-unh/"
    },
    {
     "text": "BSX Boston Scientific Corp. NYSE $43.10 -4.14%",
     "url": "https://clearank.com/stock/boston-scientific-bsx/"
    },
    {
     "text": "AMGN Amgen Inc. NASDAQ $378.76 -0.9700%",
     "url": "https://clearank.com/stock/amgen-amgn/"
    },
    {
     "text": "MRK Merck & Co., Inc. NYSE $147.53 -0.6264%",
     "url": "https://clearank.com/stock/merck-mrk/"
    },
    {
     "text": "IONS Ionis Pharmaceuticals, Inc. NASDAQ $55.65 -0.6605%",
     "url": "https://clearank.com/stock/ions-stock-analysis/"
    },
    {
     "text": "BIIB Biogen Inc. NASDAQ $215.43 +2.23%",
     "url": "https://clearank.com/stock/biib-stock-analysis/"
    },
    {
     "text": "OFIX Orthofix Medical Inc. NASDAQ $8.91 +2.53%",
     "url": "https://clearank.com/stock/ofix-stock-analysis/"
    }
   ]
  },
  {
   "id": "related-comparisons",
   "title": "Popular Comparisons",
   "links": [
    {
     "text": "CARR vs TT Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/carr-vs-tt/"
    },
    {
     "text": "XOM vs CVX Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/xom-vs-cvx/"
    },
    {
     "text": "SOFI vs AFRM Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/sofi-vs-afrm/"
    }
   ]
  },
  {
   "id": "insider-trading",
   "title": "TLRY Insider Trading Analysis",
   "facts": {
    "Bought": "$192.8K",
    "Sold": "$232.9K",
    "Insiders": "10",
    "Avg Transaction": "$60.8K"
   },
   "tables": [
    {
     "caption": "Recent insider transactions in TLRY",
     "columns": [
      "Date",
      "Insider",
      "Type",
      "Shares",
      "Value"
     ],
     "rows": [
      {
       "label": "Jun 18, 2021",
       "cells": [
        "KENNEDY BRENDAN Director",
        "Sell",
        "800.0K",
        "$14.1M"
       ]
      },
      {
       "label": "Jan 24, 2019",
       "cells": [
        "KENNEDY BRENDAN Chief Executive Officer",
        "Sell",
        "149.9K",
        "$11.1M"
       ]
      },
      {
       "label": "Jul 16, 2021",
       "cells": [
        "KENNEDY BRENDAN Director",
        "Sell",
        "600.0K",
        "$8.6M"
       ]
      },
      {
       "label": "Aug 5, 2021",
       "cells": [
        "KENNEDY BRENDAN Director",
        "Sell",
        "600.0K",
        "$8.6M"
       ]
      },
      {
       "label": "Mar 1, 2019",
       "cells": [
        "KENNEDY BRENDAN Chief Executive Officer",
        "Sell",
        "87.1K",
        "$7.0M"
       ]
      },
      {
       "label": "Apr 2, 2019",
       "cells": [
        "KENNEDY BRENDAN Chief Executive Officer",
        "Sell",
        "106.1K",
        "$6.7M"
       ]
      },
      {
       "label": "Nov 6, 2020",
       "cells": [
        "KENNEDY BRENDAN Chief Executive Officer",
        "Sell",
        "400.0K",
        "$3.9M"
       ]
      },
      {
       "label": "Feb 25, 2019",
       "cells": [
        "CASTANEDA MARK Chief Financial Officer",
        "Sell",
        "40.0K",
        "$3.1M"
       ]
      },
      {
       "label": "Nov 5, 2020",
       "cells": [
        "KENNEDY BRENDAN Chief Executive Officer",
        "Sell",
        "400.0K",
        "$3.0M"
       ]
      },
      {
       "label": "Apr 2, 2019",
       "cells": [
        "PASTORIUS EDWARD WOOD JR Officer",
        "Sell",
        "46.6K",
        "$3.0M"
       ]
      }
     ]
    }
   ],
   "links": [
    {
     "text": "SEC Form 4",
     "url": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&company=Tilray+Brands+Inc.&type=4&dateb=&owner=include&count=40&search_text=&action=getcompany"
    }
   ]
  },
  {
   "id": "faq",
   "title": "Frequently Asked Questions"
  }
 ],
 "faq": [
  {
   "question": "What is Tilray Brands Inc.'s stock price prediction for 2030?",
   "answer": "Tilray Brands Inc.'s long-range projection for 2030 indicates a base case price of $2.07, with a downside scenario at $0.57 and an upside scenario at $7.45. These figures are derived from Monte Carlo simulations and should not be considered definitive price targets or guarantees."
  },
  {
   "question": "Is Tilray Brands Inc. stock a buy right now?",
   "answer": "With a current price of $4.015, Tilray Brands Inc. is trading below its 50-day and 200-day moving averages ($4.43 and $6.53) and has an oversold RSI at 16.9. While the median analyst target price suggests potential upside, the negative revenue growth and recent earnings misses present significant risks, making it a speculative buy at best."
  },
  {
   "question": "What are the biggest risks facing Tilray Brands Inc.?",
   "answer": "The primary risks for Tilray Brands Inc. include its negative revenue growth, a pattern of missing earnings estimates, and significant technical weakness indicated by its trading below key moving averages. Insider selling also suggests a lack of management confidence in the near-term outlook."
  },
  {
   "question": "How does Tilray Brands Inc. compare to its sector averages?",
   "answer": "Tilray Brands Inc. lags its Healthcare sector peers with negative revenue growth of -7.8%, compared to the sector average of 10.0%. Its negative EPS also prevents a direct comparison of P/E ratios, indicating it is not performing in line with the sector's profitability metrics."
  },
  {
   "question": "What is the current technical outlook for Tilray Brands Inc. stock?",
   "answer": "The technical outlook for Tilray Brands Inc. is bearish, with the stock trading below its 50-day and 200-day moving averages ($4.43 and $6.53) and exhibiting oversold conditions on the RSI. The MACD also indicates downward momentum, suggesting further price declines are possible despite the oversold technicals."
  },
  {
   "question": "What are the recent earnings results for Tilray Brands Inc.?",
   "answer": "Tilray Brands Inc. recently reported an EPS of $0.05, missing analyst estimates of $0.21 by 76.19%. This follows a prior quarter where the company also missed expectations, highlighting a trend of underperformance in earnings."
  },
  {
   "question": "What is the consensus rating for Tilray Brands Inc. among Wall Street analysts?",
   "answer": "The consensus rating for Tilray Brands Inc. among Wall Street analysts is 'Buy', with one analyst issuing this rating. The median price target from analysts is $5.75, suggesting a potential upside of 43.2% from the current price of $4.015."
  }
 ],
 "related": {
  "peopleAlsoWatch": [
   {
    "ticker": "HIMS",
    "name": "Hims & Hers Health, Inc. NYSE",
    "price": "$27.52",
    "change": "+0.2733%",
    "url": "https://clearank.com/stock/hims-hers-health-hims/"
   },
   {
    "ticker": "UNH",
    "name": "UnitedHealth Group Inc. NYSE",
    "price": "$388.28",
    "change": "-1.22%",
    "url": "https://clearank.com/stock/unitedhealth-group-unh/"
   },
   {
    "ticker": "BSX",
    "name": "Boston Scientific Corp. NYSE",
    "price": "$43.10",
    "change": "-4.14%",
    "url": "https://clearank.com/stock/boston-scientific-bsx/"
   },
   {
    "ticker": "AMGN",
    "name": "Amgen Inc. NASDAQ",
    "price": "$378.76",
    "change": "-0.9700%",
    "url": "https://clearank.com/stock/amgen-amgn/"
   },
   {
    "ticker": "MRK",
    "name": "Merck & Co., Inc. NYSE",
    "price": "$147.53",
    "change": "-0.6264%",
    "url": "https://clearank.com/stock/merck-mrk/"
   },
   {
    "ticker": "IONS",
    "name": "Ionis Pharmaceuticals, Inc. NASDAQ",
    "price": "$55.65",
    "change": "-0.6605%",
    "url": "https://clearank.com/stock/ions-stock-analysis/"
   },
   {
    "ticker": "BIIB",
    "name": "Biogen Inc. NASDAQ",
    "price": "$215.43",
    "change": "+2.23%",
    "url": "https://clearank.com/stock/biib-stock-analysis/"
   },
   {
    "ticker": "OFIX",
    "name": "Orthofix Medical Inc. NASDAQ",
    "price": "$8.91",
    "change": "+2.53%",
    "url": "https://clearank.com/stock/ofix-stock-analysis/"
   }
  ],
  "comparisons": [
   {
    "ticker": "CARR vs TT Comparison",
    "name": "",
    "url": "https://clearank.com/compare/carr-vs-tt/"
   },
   {
    "ticker": "XOM vs CVX Comparison",
    "name": "",
    "url": "https://clearank.com/compare/xom-vs-cvx/"
   },
   {
    "ticker": "SOFI vs AFRM Comparison",
    "name": "",
    "url": "https://clearank.com/compare/sofi-vs-afrm/"
   }
  ],
  "sectorHub": {
   "text": "Browse all Healthcare →",
   "url": "https://clearank.com/sector/healthcare/"
  },
  "Newly Tracked": [
   {
    "ticker": "ILMN",
    "text": "Illumina Inc.",
    "url": "https://clearank.com/stock/ilmn-stock-analysis/"
   },
   {
    "ticker": "EIS",
    "text": "iShares MSCI Israel ETF",
    "url": "https://clearank.com/etf/eis-etf-analysis/"
   },
   {
    "ticker": "GWRE",
    "text": "Guidewire Software Inc.",
    "url": "https://clearank.com/stock/gwre-stock-analysis/"
   },
   {
    "ticker": "ROST",
    "text": "Ross Stores Inc.",
    "url": "https://clearank.com/stock/rost-stock-analysis/"
   },
   {
    "ticker": "LUGDF",
    "text": "Lundin Gold Inc",
    "url": "https://clearank.com/stock/lugdf-stock-analysis/"
   }
  ],
  "Top Movers (24h)": [
   {
    "ticker": "EIGEN/USD",
    "text": "↑ 9.39%",
    "url": "https://clearank.com/crypto/eigen-usd-crypto-analysis/"
   },
   {
    "ticker": "EGLD/USD",
    "text": "↓ 9.23%",
    "url": "https://clearank.com/crypto/egld-usd-crypto-analysis/"
   },
   {
    "ticker": "AERO/USD",
    "text": "↑ 8.90%",
    "url": "https://clearank.com/crypto/aero-usd-crypto-analysis/"
   },
   {
    "ticker": "HUT",
    "text": "↑ 8.77%",
    "url": "https://clearank.com/stock/hut-stock-analysis/"
   },
   {
    "ticker": "MRNA",
    "text": "↑ 8.44%",
    "url": "https://clearank.com/stock/moderna-mrna/"
   }
  ],
  "Also in Healthcare": [
   {
    "ticker": "HIMS",
    "text": "Hims & Hers",
    "url": "https://clearank.com/stock/hims-hers-health-hims/"
   },
   {
    "ticker": "TEM",
    "text": "Tempus AI Inc",
    "url": "https://clearank.com/stock/tempus-ai-tem/"
   },
   {
    "ticker": "TMO",
    "text": "Thermo Fisher",
    "url": "https://clearank.com/stock/tmo-stock-analysis/"
   },
   {
    "ticker": "UNH",
    "text": "UnitedHealth Group",
    "url": "https://clearank.com/stock/unitedhealth-group-unh/"
   },
   {
    "ticker": "ZTS",
    "text": "Zoetis Inc.",
    "url": "https://clearank.com/stock/zts-stock-analysis/"
   }
  ]
 },
 "schema": [
  {
   "@context": "https://schema.org",
   "@graph": [
    {
     "@type": "Place",
     "@id": "https://clearank.com/#place",
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     }
    },
    {
     "@type": "Organization",
     "@id": "https://clearank.com/#organization",
     "name": "CleaRank",
     "url": "https://clearank.com",
     "sameAs": [
      "https://twitter.com/CleaRank",
      "https://www.linkedin.com/company/clearank/",
      "https://www.youtube.com/@CleaRank"
     ],
     "email": "info@clearank.com",
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     },
     "logo": {
      "@type": "ImageObject",
      "@id": "https://clearank.com/#logo",
      "url": "https://clearank.com/wp-content/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "contentUrl": "https://clearank.com/wp-content/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "caption": "CleaRank",
      "inLanguage": "en-US",
      "width": "336",
      "height": "153"
     },
     "description": "The CleaRank vision is to bring clarity to the online trading industry and protect trader interests. We use our proprietary technology, expert analysis and verified trader insights, to deliver data driven broker evaluations you can trust. Our CLEAR™ Score is our foundation, a transparent, unbiased methodology that assesses brokers and firms based on the most critical factors including regulation, fees, platform reliability, and real user experiences. We are here to change an unfair system and unlike other review sites that are influenced by partnerships or subjective opinions, CleaRank is 100% independent–abiding by our rigorous CLEAR™ editorial code. We do not accept financial incentives from brokers, so what you see is what you get with no hidden agendas, just honest, actionable feedback. Clear data. Honest reviews. That's the CleaRank promise",
     "numberOfEmployees": {
      "@type": "QuantitativeValue",
      "value": "40"
     },
     "location": {
      "@id": "https://clearank.com/#place"
     }
    },
    {
     "@type": "WebSite",
     "@id": "https://clearank.com/#website",
     "url": "https://clearank.com",
     "name": "CleaRank",
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "inLanguage": "en-US"
    },
    {
     "@type": "ImageObject",
     "@id": "https://clearank.com/wp-content/uploads/2026/08/TLRY-tilray-brands-analysis-2026-08.png",
     "url": "https://clearank.com/wp-content/uploads/2026/08/TLRY-tilray-brands-analysis-2026-08.png",
     "width": "1280",
     "height": "720",
     "caption": "Tilray Brands, Inc. (TLRY) stock price analysis chart for August 2026",
     "inLanguage": "en-US"
    },
    {
     "@type": "BreadcrumbList",
     "@id": "https://clearank.com/stock/tilray-brands-tlry/#breadcrumb",
     "itemListElement": [
      {
       "@type": "ListItem",
       "position": "1",
       "item": {
        "@id": "https://clearank.com",
        "name": "Home"
       }
      },
      {
       "@type": "ListItem",
       "position": "2",
       "item": {
        "@id": "https://clearank.com/stock/tilray-brands-tlry/",
        "name": "Tilray Brands, Inc. (TLRY) Stock Analysis"
       }
      }
     ]
    },
    {
     "@type": "WebPage",
     "@id": "https://clearank.com/stock/tilray-brands-tlry/#webpage",
     "url": "https://clearank.com/stock/tilray-brands-tlry/",
     "name": "Tilray Brands (TLRY) Stock Forecast & Price Target (2026)",
     "datePublished": "2026-08-20T09:27:35+00:00",
     "dateModified": "2026-09-11T19:22:43+00:00",
     "isPartOf": {
      "@id": "https://clearank.com/#website"
     },
     "primaryImageOfPage": {
      "@id": "https://clearank.com/wp-content/uploads/2026/08/TLRY-tilray-brands-analysis-2026-08.png"
     },
     "inLanguage": "en-US",
     "breadcrumb": {
      "@id": "https://clearank.com/stock/tilray-brands-tlry/#breadcrumb"
     }
    },
    {
     "@type": "Organization",
     "@id": "https://clearank.com/writer/clearank/",
     "name": "CleaRank",
     "description": "CleaRank's vision is to bring clarity to the online trading industry and protecting trader interests by delivering data-driven broker evaluations you can trust.",
     "url": "https://clearank.com/writer/clearank/",
     "image": {
      "@type": "ImageObject",
      "@id": "https://secure.gravatar.com/avatar/4900cf75f960a22a21f1c864e98abc4d5285fa159ea1025d0e8a9db5136e28ef?s=96&d=mm&r=g",
      "url": "https://secure.gravatar.com/avatar/4900cf75f960a22a21f1c864e98abc4d5285fa159ea1025d0e8a9db5136e28ef?s=96&d=mm&r=g",
      "caption": "CleaRank",
      "inLanguage": "en-US"
     },
     "sameAs": [
      "https://clearank.com/",
      "https://twitter.com/CleaRank",
      "https://www.linkedin.com/company/clearank/",
      "https://www.youtube.com/@CleaRank"
     ],
     "worksFor": {
      "@id": "https://clearank.com/#organization"
     },
     "logo": "https://clearank.com/wp-content/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg"
    },
    {
     "@type": "Article",
     "headline": "Tilray Brands (TLRY) Stock Forecast & Price Target (2026)",
     "datePublished": "2026-08-20T09:27:35+00:00",
     "dateModified": "2026-09-11T19:22:43+00:00",
     "author": {
      "@id": "https://clearank.com/writer/clearank/",
      "name": "CleaRank"
     },
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "description": "Is Tilray Brands (TLRY) a Buy or Sell today? Get the AI price forecast, cannabis and drinks segment outlook plus key risk levels. Updated daily.",
     "name": "Tilray Brands (TLRY) Stock Forecast & Price Target (2026)",
     "@id": "https://clearank.com/stock/tilray-brands-tlry/#richSnippet",
     "isPartOf": {
      "@id": "https://clearank.com/stock/tilray-brands-tlry/#webpage"
     },
     "image": {
      "@id": "https://clearank.com/wp-content/uploads/2026/08/TLRY-tilray-brands-analysis-2026-08.png"
     },
     "inLanguage": "en-US",
     "mainEntityOfPage": {
      "@id": "https://clearank.com/stock/tilray-brands-tlry/#webpage"
     }
    }
   ]
  },
  {
   "@context": "https://schema.org",
   "@type": "FinancialProduct",
   "name": "Tilray Brands Inc. (TLRY)",
   "tickerSymbol": "TLRY",
   "url": "https://clearank.com/stock/tilray-brands-tlry/",
   "description": "AI-powered financial analysis for Tilray Brands Inc. (TLRY) including technical indicators, market metrics, valuation, and price targets - refreshed daily by CleaRank Financial AI.",
   "exchange": "NASDAQ",
   "offers": {
    "@type": "Offer",
    "price": 4.015,
    "priceCurrency": "USD",
    "availability": "https://schema.org/InStock",
    "url": "https://clearank.com/stock/tilray-brands-tlry/",
    "priceValidUntil": "2026-09-12"
   }
  },
  {
   "@context": "https://schema.org",
   "@type": "FAQPage",
   "mainEntity": [
    {
     "@type": "Question",
     "name": "What is Tilray Brands Inc.'s stock price prediction for 2030?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Tilray Brands Inc.'s long-range projection for 2030 indicates a base case price of $2.07, with a downside scenario at $0.57 and an upside scenario at $7.45. These figures are derived from Monte Carlo simulations and should not be considered definitive price targets or guarantees."
     }
    },
    {
     "@type": "Question",
     "name": "Is Tilray Brands Inc. stock a buy right now?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "With a current price of $4.015, Tilray Brands Inc. is trading below its 50-day and 200-day moving averages and has an oversold RSI of 16.87. While the median analyst target price suggests potential upside, the negative revenue growth and recent earnings misses present significant risks, making it a speculative buy at best."
     }
    },
    {
     "@type": "Question",
     "name": "What are the biggest risks facing Tilray Brands Inc.?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "The primary risks for Tilray Brands Inc. include its negative revenue growth, a pattern of missing earnings estimates, and significant technical weakness indicated by its trading below key moving averages. Insider selling also suggests a lack of management confidence in the near-term outlook."
     }
    },
    {
     "@type": "Question",
     "name": "How does Tilray Brands Inc. compare to its sector averages?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Tilray Brands Inc. lags its Healthcare sector peers with negative revenue growth of -7.8%, compared to the sector average of 10.0%. Its negative EPS also prevents a direct comparison of P/E ratios, indicating it is not performing in line with the sector's profitability metrics."
     }
    },
    {
     "@type": "Question",
     "name": "What is the current technical outlook for Tilray Brands Inc. stock?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "The technical outlook for Tilray Brands Inc. is bearish, with the stock trading below its 50-day and 200-day SMAs and exhibiting oversold conditions on the RSI. The MACD also indicates downward momentum, suggesting further price declines are possible despite the oversold technicals."
     }
    },
    {
     "@type": "Question",
     "name": "What are the recent earnings results for Tilray Brands Inc.?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Tilray Brands Inc. recently reported an EPS of $0.05, missing analyst estimates of $0.21 by 76.19%. This follows a prior quarter where the company also missed expectations, highlighting a trend of underperformance in earnings."
     }
    },
    {
     "@type": "Question",
     "name": "What is the consensus rating for Tilray Brands Inc. among Wall Street analysts?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "The consensus rating for Tilray Brands Inc. among Wall Street analysts is 'Buy', with one analyst issuing this rating. The median price target from analysts is $5.75, suggesting a potential upside of 43.2% from the current price of $4.015."
     }
    }
   ]
  }
 ]
}